Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021


HomeFUNDINGHomeDoctor Raises €3,7m Series A Funding Led by Cogito Capital Partners

HomeDoctor Raises €3,7m Series A Funding Led by Cogito Capital Partners

October 1, 2020

HomeDoctor is a Warsaw and Amsterdam-based digital healthcare provider.

HomeDoctor announced a €3,7m Series A funding round led by Cogito Capital Partners with participation from the Company’s founders. HomeDoctor, founded in 2016, is a leader in the Polish market in providing online medical consultations and delivery of healthcare services to patients’ homes. The Company is operating as a b2b2c and a b2c medical services platform that enables delivery of both, online and phone consultations (telemedicine channel) and booking a doctor appointment (home visit).

HomeDoctor is also a key partner for the largest medical centers and insurers in Poland. They developed an effective and patient-centric healthcare model that combines complementary digital and physical consultations. HomeDoctor’s services are available online as well as through a dedicated mobile app (connecting doctors and patients). For home-visits business, the Company uses geo-location technology, to ensure that the nearest available doctor is dispatched to a patient, which allows for the delivery of a home visit within 1 hour of wait time. This feature, combined with over 200 GPs dedicated to home-visits, gives HomeDoctor a unique competitive advantage and a clear leadership position in Poland. The Company works with over 350 doctors (GPs as well as 16 different specializations) who call on patients across Poland. With the onset of the COVID-19 pandemic, the Company recorded an unprecedented growth in demand, especially in teleconsultations.

Also, the Q3 2020 data shows a dynamic growth in the number of home visits. This model gives the Company a competitive advantage and enables for patient-centric innovations. HomeDoctor’s ambitious growth strategy focuses on further product development – telemedicine consultation service (telco/video), both in the b2b and b2b2c models, expansion of home visits, and an integrated online pharmacy as well as tailored offerings for enterprise customers. HomeDoctor will use the investment to continue the growth of its operations in Poland, building its team and capacity in order to further expand geographically and build strategic partnerships aimed at scaling-up the Company’s offering and market reach. The Company plans on expanding its services to other European countries, building on growing adoption of telemedicine, regulatory changes, and developments in digital healthcare across Europe. Recent regulatory and reimbursement changes allow digital healthcare providers to be part of the publicly funded healthcare systems and thus increase access to highly competent and experienced medical professionals in the European countries.

The team behind HomeDoctor comprises of serial entrepreneurs and business executives, who have successfully built and scaled both enterprise and consumer-focused businesses. Szymon Horaczuk, the Founder and CEO of HomeDoctor said:

“Home Doctor’s mission is to transform the traditional healthcare model challenged by accessibility issues and deliver healthcare services to consumers in a seamless, patient-centric way. We are delighted to have Cogito on board, to support our plans and strengthen our capacity to execute our ambitious growth and expansion strategy”. Sylwester Janik, General Partner at Cogito said: “We are excited to partner with Szymon and his team to support HomeDoctor’s product and market expansion plans. The Company’s offering meets patients’ needs and preferences for affordable and accessible healthcare services, conveniently delivered online and directly to their homes, and is a game-changer in the healthcare industry”.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy